NASDAQ:OSUR - OraSure Technologies Stock Price, Forecast & News

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

OraSure Technologies, Inc. (NASDAQ:OSUR) announced its quarterly earnings data on Wednesday, November, 6th. The medical instruments supplier reported $0.21 EPS for the quarter, beating the Zacks' consensus estimate of $0.03 by $0.18. The medical instruments supplier earned $35.99 million during the quarter, compared to the consensus estimate of $38.62 million. OraSure Technologies had a return on equity of 5.93% and a net margin of 15.80%. The business's revenue for the quarter was down 21.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.13 earnings per share. View OraSure Technologies' Earnings History.

OraSure Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for OraSure Technologies.

OraSure Technologies updated its FY19 earnings guidance on Wednesday, November, 6th. The company provided earnings per share (EPS) guidance of $0.28-0.31 for the period, compared to the Thomson Reuters consensus estimate of $0.32. The company issued revenue guidance of $150-153 million, compared to the consensus revenue estimate of $162.58 million.

1 brokerages have issued 12 month price objectives for OraSure Technologies' shares. Their forecasts range from $8.00 to $8.00. On average, they expect OraSure Technologies' stock price to reach $8.00 in the next year. This suggests that the stock has a possible downside of 2.7%. View Analyst Price Targets for OraSure Technologies.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for OraSure Technologies.

News coverage about OSUR stock has been trending somewhat negative this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. OraSure Technologies earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for OraSure Technologies.

Some companies that are related to OraSure Technologies include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), XOMA (XOMA), Energy Transfer LP Unit (ET), Overstock.com (OSTK), Ford Motor (F), CBL & Associates Properties (CBL), Celldex Therapeutics (CLDX), SandRidge Permian Trust (PER) and Cornerstone Total Return Fund (CRF).

OraSure Technologies' stock is owned by a number of of retail and institutional investors. Top institutional investors include Assenagon Asset Management S.A. (0.48%), First Hawaiian Bank (0.13%), Alpine Global Management LLC (0.05%), Louisiana State Employees Retirement System (0.03%) and Lenox Wealth Advisors LLC (0.01%). Company insiders that own OraSure Technologies stock include Brian Smith, Charles W Patrick, Jack E Jerrett, Roberto Cuca and Stephen S Phd Tang. View Institutional Ownership Trends for OraSure Technologies.

OSUR stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., First Hawaiian Bank and Louisiana State Employees Retirement System. View Insider Buying and Selling for OraSure Technologies.

OSUR stock was acquired by a variety of institutional investors in the last quarter, including Alpine Global Management LLC and Lenox Wealth Advisors LLC. Company insiders that have bought OraSure Technologies stock in the last two years include Jack E Jerrett, Roberto Cuca and Stephen S Phd Tang. View Insider Buying and Selling for OraSure Technologies.

Shares of OSUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OSUR stock can currently be purchased for approximately $8.22.

OraSure Technologies has a market capitalization of $507.39 million and generates $181.74 million in revenue each year. The medical instruments supplier earns $20.40 million in net income (profit) each year or $0.50 on an earnings per share basis. OraSure Technologies employs 398 workers across the globe.View Additional Information About OraSure Technologies.

The official website for OraSure Technologies is http://www.orasure.com/.

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The medical instruments supplier can be reached via phone at 610-882-1820 or via email at [email protected]